Now showing items 1-1 of 1
A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
(Kluwer Academic Publishers; Springer Science + Business Media, Inc., 2005-12)
Background . Pancreatic cancer is amongst the most chemoresistant malignancies. Expression of the cyclooxygenase-2 (COX-2) enzyme plays a major role in tumor progression and resistance to therapy. A Phase II study was ...